Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

GSK signs Adaptimmune deal

June 3, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology

GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …

News
gsk image

GSK pondering £7.5 billion drugs sale

May 30, 2014
Sales and Marketing GSK, Paxil, ageing, drugs, established, imitrex, zofran

GlaxoSmithKline is looking to make more than £7 billion by selling off its ageing portfolio of established drugs. This is …

News
GSK image

GSK now faces UK investigation

May 28, 2014
Medical Communications, Research and Development, Sales and Marketing China, GSK, Poland, UK, bribery, corruption, iraq, sfo

The woes of GlaxoSmithKline look set to continue as the UK’s Serious Fraud Office (SFO) has launched a criminal probe …

News
Roche image

Authorities visit Roche China offices

May 23, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing China, GSK, Roche, Witty, hangzhou, saic

A unit of China’s antitrust regulator has visited Roche’s offices in Hangzhou, according to media reports. The pharma industry has …

News
GSK logo

GSK’s Arzerra fails in lymphoma

May 21, 2014
Research and Development, Sales and Marketing Arzerra, GSK, Genmab, non-Hodgkin lymphoma

News
FDA logo

Heartbreak for Novartis as FDA rejects drug

May 18, 2014
Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

News
GSK image

More late-stage anguish for GSK heart drug

May 14, 2014
Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart

GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …

News
GSK image

GSK China head arrested over bribery charges

May 14, 2014
Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly

A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …

News

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014
Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

News
GSK image

GSK sees profit fall

May 1, 2014
Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty

GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …

News
PM awards image

Pharma playing catch-up in mHealth race

April 30, 2014
Medical Communications, Sales and Marketing GSK, Havas, butler, digital, gait, mhealth, mobile health, pm awards

Pharma risks falling behind in mobile health (mHealth) as more innovative industries capitalise on its emerging opportunities, according to two …

News
gsk image

Mekinist shown green light by CHMP

April 28, 2014
Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib

GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …

News
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News

GSK and Novartis sign multi-billion dollar deal

April 23, 2014
Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines

GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …

News
GSK image

GSK bribery controversy spreads to Poland

April 14, 2014
Medical Communications, Sales and Marketing China, FDA, GSK, Witty, bribery, cctv, iraq

Poland has become the latest country in a string of bribery claims to hit GSK as it faces legal action …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025